SCHEMBL7316770

SCHEMBL7316770

OC1(c2cccs2)c2ccccc2-c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 9/20 0.43
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
OPRM1 P35372 2/20 0.37
OPRL1 P41146 2/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
ALDH1A1 P00352 1/20 0.34
SLC6A2 P23975 1/20 0.33
MEN1 O00255 1/20 0.33
PRCP P42785 1/20 0.33
KMT2A Q03164 1/20 0.33
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316176 0.86 PDK2 (0.50) PDK2TDP1ALDH1A1MEN1KMT2A
SCHEMBL7320725 0.84 PDK2 (0.51) PDK2
SCHEMBL7323011 0.82 PDK2 (0.53) PDK2MEN1KMT2A
SCHEMBL7322740 0.82 PDK2 (0.53) PDK2TDP1HSP90AA1ALDH1A1MEN1
SCHEMBL7315243 0.82 PDK2 (0.41) PDK2ALDH1A1
SCHEMBL7315587 0.81 KDM4E (0.36) PDK2OPRM1OPRL1OPRD1OPRK1
SCHEMBL7319059 0.79 CHRM2 (0.42) OPRM1OPRL1OPRD1OPRK1CHRM2
SCHEMBL27755004 0.73 MEN1 (0.44) PDK2THRBTDP1OPRM1OPRL1
SCHEMBL21880270 0.72 PDK2 (0.41) PDK2THRBTDP1HSP90AA1HSP90AB1
SCHEMBL7555085 0.72 CHRM2 (0.37) OPRM1OPRL1OPRD1OPRK1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO disclosed